Neuromuscular blocking agents during targeted temperature management for out-of-hospital cardiac arrest patients - 03/06/24
, Makoto Aoki, MD, PhD a, g, Nobuya Kitamura, MD, PhD b, Takashi Tagami, MD, MPH, PhD c, Kei Hayashida, MD, PhD d, Shotaro Aso, MD, MPH, PhD e, Hideo Yasunaga, MD, PhD f, Mitsunobu Nakamura, MD aon behalf of the SOS-KANTO 2017 Study Group
Abstract |
Background |
Neuromuscular blocking agents (NMBAs) can control shivering during targeted temperature management (TTM) of patients with cardiac arrest. However, the effectiveness of NMBA use during TTM on neurologic outcomes remains unclear. We aimed to evaluate the association between NMBA use during TTM and favorable neurologic outcomes after out-of-hospital cardiac arrest (OHCA).
Materials and methods |
A multicenter, prospective, observational cohort study from 2019 to 2021. It included OHCA patients who received TTM after hospitalization. We conducted overlap weight propensity-score analyses after multiple imputation to evaluate the effect of NMBAs during TTM. The primary outcome was a favorable neurological outcome, defined as a cerebral performance category of 1 or 2 at discharge. Subgroup analyses were conducted based on initial monitored rhythm and brain computed tomography findings.
Results |
Of the 516 eligible patients, 337 received NMBAs during TTM. In crude analysis, the proportion of patients with favorable neurological outcome was significantly higher in the NMBA group (38.3% vs. 16.8%; risk difference (RD): 21.5%; 95% confidence interval (CI): 14.0% to 29.1%). In weighted analysis, a significantly higher proportion of patients in the NMBA group had a favorable neurological outcome compared to the non-NMBA group (32.7% vs. 20.9%; RD: 11.8%; 95% CI: 1.2% to 22.3%). In the subgroup with an initial shockable rhythm and no hypoxic encephalopathy, the NMBA group showed significantly higher proportions of favorable neurological outcomes.
Conclusions |
The use of NMBAs during TTM was significantly associated with favorable neurologic outcomes at discharge for OHCA patients. NMBAs may have benefits in selected patients with initial shockable rhythm and without poor prognostic computed tomography findings.
Le texte complet de cet article est disponible en PDF.Keywords : Out-of-hospital cardiac arrest, Targeted temperature management, Neuromuscular blocking agents
Abbreviations : TTM, OHCA, NMBAs, RCT, ROSC, CPC, CPR, CT, GWR, IQR, ASD, RD, CI
Plan
Vol 81
P. 86-91 - juillet 2024 Retour au numéro
Article précédent
- Development and validation of a clinico-biological score to predict outcomes in patients with drowning-associated cardiac arrest
- Florian Reizine, Pierre Michelet, Agathe Delbove, Guillaume Rieul, Laetitia Bodenes, Pierre Bouju, Pierre Fillâtre, Aurélien Frérou, Olivier Lesieur, Thibaut Markarian, Arnaud Gacouin, on behalf of the DrownAP study group
- Seven- and thirty-day mortality in digoxin poisoning: Results from the DIGITOX study
- August Supervía, Antonio F. Caballero-Bermejo, Jordi Puiguriguer, Francisca Córdoba, Andrea Martínez-Baladrón, Francisco Callado, Victoria Lobo-Antuña, Elena Fuentes, Valle Molina-Samper, Susana Vert, Francisco Ruíz-Ruíz, F. Javier Guijarro-Eguinoa, Beatriz Martín-Pérez, Samuel Olmos, Belén Ruiz-Antorán, María Teresa Maza-Vera, Oriol Pallàs, Benjamín Climent, Maider Igartua-Astibia, Edith Gutiérrez, Santiago Nogué, Ana Ferrer-Dufol, Guillermo Burillo-Putze
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?